PCNA and melanoma: Because these pathways drive proliferation, we next analyzed the proliferative capacity of nf1/pten-mutant melanomas, observing high levels of expression of proliferating cell nuclear antigen (PCNA) in 45% of tumor-cell nuclei but not the adjacent normal tissue (Fig. 1f), indicating a high tumor proliferative rate.